Epigral Limited (BOM:543332)

Market Cap	38.12B -51.1%
Revenue (ttm)	24.19B -1.2%
Net Income	3.38B -2.9%
EPS	78.35 -5.8%
Shares Out	n/a
PE Ratio	11.28
Forward PE	12.73
Dividend	3.50 (0.40%)
Ex-Dividend Date	Jun 20, 2025

Volume	2,114
Average Volume	4,722
Open	848.00
Previous Close	869.50
Day's Range	835.00 - 886.90
52-Week Range	806.20 - 2,114.30
Beta	n/a
RSI	48.67
Earnings Date	Apr 23, 2026

About Epigral

Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins and compounds, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agroc...

• Industry: Chemicals and Allied Products
• Founded: 2007
• Employees: 1,072
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543332

Financial Performance

In fiscal year 2025, Epigral's revenue was 25.50 billion, an increase of 32.19% compared to the previous year's 19.29 billion. Earnings were 3.58 billion, an increase of 82.62%.